CIK 0000318154
- Large accelerated filer
AMGEN INC
Sign in to watch- Ticker
- AMGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 953540776
- Phone
- +1 805-447-1000
- Business address
- ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-07 | Busch Matthew C. VP, Finance & CAO | Grant or award | +333 | 4,932 | ||
| 2024-05-07 | Busch Matthew C. VP, Finance & CAO | Grant or award · Nqso (Right to Buy) | +2,163 | $300.30 | $650K | 2,163 |
| 2024-05-05 | Busch Matthew C. VP, Finance & CAO | Shares withheld for taxes | −27 | $311.29 | $8K | 4,599 |
| 2024-05-02 | Busch Matthew C. VP, Finance & CAO | Shares withheld for taxes | −27 | $277.37 | $7K | 4,626 |
| 2024-04-30 | Busch Matthew C. VP, Finance & CAO | Shares withheld for taxes | −17 | $276.38 | $5K | 4,653 |
| 2024-03-18 | Busch Matthew C. VP, Finance & CAO | Shares withheld for taxes | −146 | $268.87 | $39K | 4,670 |
| 2024-03-06 | Busch Matthew C. VP, Finance & CAO | Grant or award | +418 | 4,799 | ||
| 2023-11-05 | Busch Matthew C. VP, Finance & CAO | Shares withheld for taxes | −66 | $269.86 | $18K | 4,550 |
| 2023-11-05 | Busch Matthew C. VP, Finance & CAO | Shares withheld for taxes | −183 | $269.86 | $49K | 4,367 |
Page 2 of 2 · 29 trades